开发用于瘤化疗免疫疗法的金复合体
Suxing Jin1,2, Yan Guo3, Xiaoyong Wang2
1School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, 210023, P. R. China.
Chemistry (Weinheim an der Bergstrasse, Germany)
|January 3, 2024
概括
复合物通过将化疗与免疫疗法相结合来增强癌症治疗. 这些化合物不仅可以杀死瘤细胞,还可以调节免疫系统,改善药物耐药性和减少毒性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药用化学 医学化学
背景情况:
- 复合物是已知的化疗剂.
- 新出现的证据强调了它们在抗瘤活性中的免疫调节作用.
- 结合化疗和免疫疗法提供了增强的治疗潜力.
研究的目的:
- 审查化疗免疫治疗的概念.
- 总结一下复合物的近期进展,作为化疗免疫治疗剂.
- 探索复合物在癌症治疗中的多方面的作用.
主要方法:
- 化学免疫疗法和复合物的文献综述.
- 分析复合体诱导免疫细胞死亡的机制.
- 检查复合体在免疫检查点封锁和免疫信号调节中的作用.
主要成果:
- 复合体表现出细胞毒性和免疫调节作用.
- 它们可以被开发为诱导免疫细胞死亡的诱导剂.
- 复合体作为免疫检查点阻断剂和瘤免疫微环境的调节剂.
结论:
- 与复合物的协同化疗免疫疗法增强了抗瘤活性.
- 这种方法有助于克服耐药性和全身毒性.
- 复合物为开发基于金属的抗癌药物提供了新的途径.
更多相关视频
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


